Pharmasset Inc. (VRUS) Income Statement

Income Statement for Pharmasset Inc.  (VRUS) 
$ N/A N/A (N/A) Volume: N/A
Statement: View:
Income [+] in Thousands of Dollars
09/2011 09/2010 09/2009 09/2008 09/2007
Operating Revenue 897 1,020 13,293 1,857 22,009
Total Revenue 897 1,020 13,293 1,857 22,009
Adjustments to Revenue - - - - -
Cost of Revenue 598 858 987 995 892
Cost of Sales With Depreciation - - - - -
Gross Margin 1,495 1,878 14,280 2,852 22,902
Gross Operating Profit 1,495 1,878 14,280 2,852 22,902
Selling/General/Admin Expense (16,651) (16,458) (13,365) (13,289) (9,211)
Research & Development (75,850) (48,261) (52,552) (42,995) (20,319)
Advertising - - - - -
EBITDA (Operating Income Before Depreciation) (91,006) (62,841) (51,637) (53,432) (6,628)
Depreciation & Amortization (598) (858) (987) (995) (892)
Depreciation, Unreconciled - - - - -
Amortization - - - - -
Amortization of Intangibles - - - - -
Operating Income (91,604) (63,699) (52,624) (54,428) (7,520)
Operating Profit After Depreciation (91,604) (63,699) (52,624) (54,428) (7,520)
Interest Income - - - - -
Earnings from Equity Interest - - - - -
Other Income, Net 504 8 221 1,986 2,471
Income, Acquired in Process R&D - - - - -
Income, Restructuring and M&A - - - - -
Other Special Charges - - - - -
Total Income Before Interest Expense (EBIT) (91,100) (63,691) (52,403) (52,441) (5,050)
Interest Expense (1,058) (2,391) (3,190) (2,216) (15)
Income Before Tax (92,158) (66,082) (55,593) (54,658) (5,065)
Income Taxes 973 - - - -
Minority Interest - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Other Special Charges (92,158) (66,082) (55,593) (54,658) (5,065)
Net Income from Continuing Operations (91,185) (66,082) (55,593) (54,658) (5,065)
Net Income from Discontinued Operations - - - - -
Net Income from Total Operations (91,185) (66,082) (55,593) (54,658) (5,065)
Normalized Income (91,185) (66,082) (55,593) (54,658) (5,065)
Extraordinary Income/Loss - - - - -
Special Income/Charges - - - - -
Income from Cum. Effect of Acct Change - - - - -
Income from Tax Loss Carryforward - - - - -
Net Income Available for Common (91,185) (66,082) (55,593) (54,658) (6,840)
Other Gains - - - - -
Total Net Income (91,185) (66,082) (55,593) (54,658) (5,065)
Net Income Available for Common (91,185) (66,082) (55,593) (54,658) (6,840)
Results [+] in Dollars (Preferred Dividends in Thousands)
09/2011 09/2010 09/2009 09/2008 09/2007
Dividends Paid Per Share 0.00 0.00 0.00 0.00 0.00
Preferred Dividends - - - - 1,776
Basic EPS from Continuing Operations -1.25 -1.07 -1.05 -1.26 -0.23
Basic EPS from Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Basic EPS from Extraordinary Income Gains/Losses 0.00 0.00 0.00 0.00 0.00
Basic EPS from Cumulative Effect of Accounting Change 0.00 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryforward 0.00 0.00 0.00 0.00 0.00
Basic EPS from Other Gains/Losses 0.00 0.00 0.00 0.00 0.00
Basic EPS from Total Net Income -1.25 -1.07 -1.05 -1.26 -0.23
Basic Normalized Net Income per Share -1.25 -1.07 -1.05 -1.26 -0.23
Basic EPS from Total Operations -1.25 -1.07 -1.05 -1.26 -0.23
Diluted EPS from Continuing Operations -1.25 -1.07 -1.05 -1.26 -0.23
Diluted EPS from Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Extraordinary Gains/Losses 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Cumulative Effect of Accounting Change 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Tax Loss Carryforward 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Other Gains/Losses 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Total Net Income -1.25 -1.07 -1.05 -1.26 -0.23
Diluted Normalized Net Income per Share -1.25 -1.07 -1.05 -1.26 -0.23
Excise Tax - - - - -
Diluted EPS from Total Operations -1.25 -1.07 -1.05 -1.26 -0.23